Medisix Therapeutics Pte
Latest round
- Series A
Last raised
- Feb 2018
Total raised
- $20M
Investors
- 3
About Medisix Therapeutics Pte
Medisix Therapeutics Pte Ltd.Founded in 2016, Medisix Therapeutics is based in Singapore and specializes in biotechnology. Andrew Bruce is the CEO, leading the company towards advancing T-cell therapy.Medisix Therapeutics develops cutting-edge T-cell therapies, prominently featuring its PEBL (Protein Expression BLocker) technology that enhances CAR T-cell therapies.In 2023, Medisix Therapeutics reported zero revenue and an EBITDA loss of USD 28,763,317.36 mn from September 2019 to further develop its PEBL technology and expand into new markets. Upcoming product launches are expected to include enhancements to current therapies, with specific geographic expansions being targeted in Asia and the United States by 2025. The company aims to establish a solid pipeline for future clinical trials and commercialization.
Who invested in Medisix Therapeutics Pte
3 investors across 1 round
See all investors in Medisix Therapeutics Pte
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Feb 7, 2018
Amount
$20M
Investors
Questions about Medisix Therapeutics Pte
Who invested in Medisix Therapeutics Pte?
Medisix Therapeutics Pte has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Medisix Therapeutics Pte raised?
Medisix Therapeutics Pte has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Medisix Therapeutics Pte last raise money?
Medisix Therapeutics Pte's most recent round on record is a Series A, in Feb 2018.
What does Medisix Therapeutics Pte do?
Medisix Therapeutics Pte is a biotechnology company.
Where is Medisix Therapeutics Pte headquartered?
Medisix Therapeutics Pte is headquartered in Singapore, Singapore.
Which VCs invest in companies like Medisix Therapeutics Pte?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Medisix Therapeutics Pte's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Medisix Therapeutics Pte? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.